035610 — Solborn Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapContrarian

Market Cap
KR₩104bn
Enterprise Value
KR₩25bn
Revenue
KR₩122bn

Annual income statement for Solborn, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	82,039	100,199	93,816	119,840	121,901
Cost of Revenue
Gross Profit	45,029	55,751	22,931	80,903	81,574
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	73,280	84,536	120,653	85,960	95,811
Operating Profit	8,760	15,663	-26,837	33,880	26,091
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	7,060	33,895	-45,344	54,941	70,296
Provision for Income Taxes
Net Income After Taxes	5,141	29,967	-41,917	49,713	62,560
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	1,447	17,822	-41,712	38,249	36,921
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,447	17,822	-41,712	38,249	36,921
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	15.4	792	-1,864	1,677	1,745
Dividends per Share